In addition, it has been shown in adenocarcinomas of the lung and pancreas that NNK has identical cancer-stimulating effects as Epi and Nor by binding as an agonist to β-ARs and that propranolol inhibited these responses11, 25. This evidence concerns the gene CTBP1 and cancer.